SCHEMBL2705980

SCHEMBL2705980

NC(=O)c1c(F)ccc(OCc2ccc3ccccc3c2)c1F

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.49
HTT P42858 1/20 0.49
PPARG P37231 1/20 0.43
RAB9A P51151 1/20 0.42
PARP1 P09874 1/20 0.42
ANO1 Q5XXA6 1/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
ALOX5 P09917 2/20 0.40
CAPN1 P07384 1/20 0.40
MRGPRX4 Q96LA9 4/20 0.40
SPHK2 Q9NRA0 1/20 0.40
SPHK1 Q9NYA1 1/20 0.40
MAOB P27338 1/20 0.40
PARP10 Q53GL7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL204212 0.85 PPARG (0.47) LMNAHTTPPARGRAB9APARP1
SCHEMBL19285699 0.84 KDM1A (0.50) LMNAHTTPARP1NPC1MAPT
SCHEMBL2705646 0.83 SIRT2 (0.49) LMNAHTTMRGPRX4SPHK2SPHK1
SCHEMBL2705638 0.82 LMNA (0.48) LMNAHTTPARP1MRGPRX4
SCHEMBL202627 0.82 MAOB (0.56) LMNAHTTMRGPRX4MAOBPARP10
SCHEMBL2707206 0.82 FFAR1 (0.51) LMNAHTTMRGPRX4MAOBPARP10
SCHEMBL203855 0.82 MRGPRX4 (0.43) LMNAHTTPARP1MRGPRX4
SCHEMBL2704584 0.81 MRGPRX4 (0.48) LMNAHTTMRGPRX4
SCHEMBL2707335 0.81 MRGPRX4 (0.54) MRGPRX4MAOB
SCHEMBL2705640 0.81 MRGPRX4 (0.52) LMNAHTTRAB9ANPC1MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-20150191420-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. 2015-07-09 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-8865736-B2 Antibacterial agents Biota Scientific Pty Ltd (AU) 2014-10-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20130072520-A2 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2013-03-21 US disclosed
US-20120122918-A1 ANTIBACTERIAL AGENTS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2012-05-17 US disclosed
US-8088791-B2 Antibacterial agents Biots Scientific Management Pty Ltd (AU) 2012-01-03 US disclosed
EP-1996180-B1 BENZAMIDE AND PYRIDYLAMIDE DERIVATIVES AS ANTIBACTERIAL AGENTS BIOTA EUROPE LTD (GB) 2011-08-03 EP disclosed
US-20100173933-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2010-07-08 US disclosed
WO-2007107758-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122918-A1 ANTIBACTERIAL AGENTS ALK, ROS1, ARG1 LMNA 3250/4885HTT 4308/4885PPARG 3846/4885
US-20130072520-A2 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 LMNA 1817/4885HTT 4286/4885PPARG 3402/4885
US-20150191420-A1 ANTIBACTERIAL AGENTS ALK, ARG1, ROS1 LMNA 2877/4885HTT 4291/4885PPARG 3677/4885
US-20100173933-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 LMNA 1817/4885HTT 4286/4885PPARG 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.